Contrasting renal effects of nicotine in smokers and non-smokers

被引:65
作者
Halimi, JM
Philippon, C
Mimran, A [1 ]
机构
[1] CHU Montpellier, Hop Lapeyronie, Dept Med, F-34295 Montpellier, France
[2] CHU Henri Mondor, Dept Biochem, F-94010 Creteil, France
关键词
cyclic GMP; humans; nicotine; renal haemodynamics; smoking;
D O I
10.1093/ndt/13.4.940
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Cigarette smoking is associated with acute increase in arterial pressure due to systemic vasoconstriction and decreased skin and coronary blood flow. Virtually all cardiovascular effects of cigarette smoking are due to nicotine. However, whether nicotine also affects the renal circulation and function in humans is at present unknown. Methods. In the current study the acute effects of a 4-mg nicotine gum on arterial pressure, heart rate as well as renal haemodynamics and function were assessed in non-smokers and chronic smokers. Results. In non-smokers, mean arterial pressure (+8+/-1 mmHg, P<0.001) and heart rate (+13+/-3 beats/min, P<0.001) increased whereas effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) decreased by 15+/-4% and 14+/-4% respectively; in addition, urinary cyclic GMP decreased by 51+/-12% in response to nicotine administration. In smokers, mean arterial pressure and heart rate increased similarly; however, in contrast with non-smokers, ERPF and GFR remained unchanged whereas urinary cyclic GMP rose by 87+/-43%. Changes in ERPF induced by nicotine were positively correlated with changes in urinary cyclic GMP. Conclusions. These findings indicate that nicotine administration is associated with renal vasoconstriction in healthy non-smokers, possibly through alteration of a cyclic-GMP-dependent vasoactive mechanism. Tolerance to the renal effect of nicotine was observed in chronic smokers, despite the maintenance of the systemic response to nicotine.
引用
收藏
页码:940 / 944
页数:5
相关论文
共 29 条
[1]   SMOKING IN RELATION TO ATHEROSCLEROSIS OF CORONARY ARTERIES [J].
AUERBACH, O ;
HAMMOND, EC ;
GARFINKE, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (15) :775-&
[2]   NITRIC-OXIDE IN THE KIDNEY - SYNTHESIS, LOCALIZATION, AND FUNCTION [J].
BACHMANN, S ;
MUNDEL, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (01) :112-129
[3]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[4]  
Blaufox MD, 1996, J NUCL MED, V37, P1883
[5]   THE ANTIDIURETIC ACTION OF NICOTINE AND OF SMOKING [J].
BURN, JH ;
TRUELOVE, LH ;
BURN, I .
BRITISH MEDICAL JOURNAL, 1945, 1 (4394) :403-406
[6]   MECHANISM OF EFFECT OF NICOTINE ON RENAL WATER EXCRETION [J].
CADNAPAPHORNCHAI, P ;
BOYKIN, JL ;
BERL, T ;
MCDONALD, KM ;
SCHRIER, RW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1974, 227 (05) :1216-1220
[7]   CIGARETTE-SMOKING IS ASSOCIATED WITH DOSE-RELATED AND POTENTIALLY REVERSIBLE IMPAIRMENT OF ENDOTHELIUM-DEPENDENT DILATION IN HEALTHY-YOUNG ADULTS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GEORGAKOPOULOS, D ;
BULL, C ;
THOMAS, O ;
ROBINSON, J ;
DEANFIELD, JE .
CIRCULATION, 1993, 88 (05) :2149-2155
[8]   NOREPINEPHRINE AND EPINEPHRINE RELEASE AND ADRENERGIC MEDIATION OF SMOKING-ASSOCIATED HEMODYNAMIC AND METABOLIC EVENTS [J].
CRYER, PE ;
HAYMOND, MW ;
SANTIAGO, JV ;
SHAH, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (11) :573-577
[9]  
DOWNEY HF, 1981, J PHARMACOL EXP THER, V216, P363
[10]  
GOERRE S, 1995, J CARDIOVASC PHARM, V26, pS236